MXCT Insider Trading
Insider Ownership Percentage: 3.00%
Insider Buying (Last 12 Months): $489,113.29
Insider Selling (Last 12 Months): $622,335.08
MaxCyte Share Price & Price History
Current Price: $2.58
Price Change: ▲ Price Increase of +0.24 (10.26%)
As of 04/11/2025 05:00 PM ET
MaxCyte Insider Trading History
MaxCyte Institutional Trading History
Data available starting January 2016
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Read More on MaxCyte
Volume
445,053 shs
Average Volume
526,412 shs
Market Capitalization
$274.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.39
Who are the company insiders with the largest holdings of MaxCyte?
MaxCyte's top insider investors include:
- Douglas Doerfler (CEO)
- Stanley C Erck (Director)
- John Joseph Johnston (Director)
- Douglas J Swirsky (CFO)
- Maher Masoud (CEO)
- David I Sandoval (General Counsel)
- Ali Soleymannezhad (Insider)
- Thomas M Ross (EVP)
- Thomas M Ross (EVP)
Learn More about top insider investors at MaxCyte.
Who are the major institutional investors of MaxCyte?
Which major investors are buying MaxCyte stock?
Within the previous quarter, MXCT stock was acquired by institutional investors including:
- Kwmg LLC